Company facts
- Headquarters
- Irvine, California
- Most recent report
- 8-K, filed Sep 17, 2026
- Incorporated
- Delaware
- Filings on record
- 275 filings
- On EDGAR
- CIK 1674632
- Fiscal year ends
- December
- Filer status
- Emerging growth company
Financials 8
News 8 of 16
Prospectuses and Registrations 8 of 11
- 424B5 Prospectus supplement for an offering Sep 17, 2026
- FWP Free writing prospectus Sep 16, 2026
- 424B5 Prospectus supplement for an offering Sep 16, 2026
- S-3ASR Automatic shelf registration Feb 24, 2026
- S-8 Registration statement for an employee plan Feb 24, 2026
- S-8 Registration statement for an employee plan Feb 3, 2025
- 424B4 Final prospectus for an offering Jan 31, 2025
- S-1/A Registration statement for an offering, amended Jan 28, 2025
Proxies 2
Ownership 8 of 192
- 4 Insider reported a trade Sep 23, 2026
- 144 Notice of a proposed sale of restricted stock Sep 22, 2026
- 4/A Insider reported a trade, amended Sep 18, 2026
- 4 Insider reported a trade Sep 17, 2026
- 4 Insider reported a trade Sep 17, 2026
- 144 Notice of a proposed sale of restricted stock Sep 16, 2026
- 144 Notice of a proposed sale of restricted stock Sep 16, 2026
- 4 Insider reported a trade Sep 15, 2026
Other 8 of 46
- ARS Annual report sent to shareholders Apr 10, 2026
- SEC STAFF LETTER Jan 29, 2025
- EFFECT Notice that a registration became effective Jan 29, 2025
- S-1MEF Jan 29, 2025
- CERT Exchange certified a listing Jan 29, 2025
- CORRESP Reply to SEC staff Jan 28, 2025
- CORRESP Reply to SEC staff Jan 28, 2025
- 8-A12B Registration of a security for exchange listing Jan 27, 2025
Everything here comes from Beta Bionics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.